Discover why Enphase Energy (ENPH) is now rated Buy despite recent declines. Learn how IRA credits and cash reserves could ...

Phio Pharmaceuticals shares were higher after the company reported positive pathology results for its Phase 1b Intasyl PH-762 trial. The stock was 32% higher, at $2.72. Shares are up 55% year to date.

Dividend investors often start first with a stock's dividend yield, which makes sense. On that score, Enbridge is very attractive. The S&P 500 index (SNPINDEX: ^GSPC) yields a miserly 1.2%. The ...

The general mood among these heavyweight investors is divided, with 35% leaning bullish and 50% bearish. Among these notable options, 10 are puts, totaling $1,372,928, and 10 are calls, amounting to ...

Enphase Energy shares are sliding Wednesday after the company issued fourth-quarter revenue guidance below analyst ...

Here are some of Wednesday's biggest stock movers: ...